What is RxAnte worth?
$28.9Mlast known valuation
RxAnte last raised $10.9M in its Debt (Oct 2020).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for RxAnte
Create free account
No card required
Funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Oct 2020 | Debt | $10.9M | ▮ | ▮ |
How RxAnte's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For RxAnte, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is RxAnte worth?
- RxAnte's last known valuation is $28.9M.
- How much has RxAnte raised?
- RxAnte has raised $49.8M in total funding across 1 recorded rounds.
- When did RxAnte last raise?
- RxAnte last raised in Oct 2020 (Debt), raising $10.9M.